These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15466114)

  • 1. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
    Sangun O; Dundar BN; Erdogan E
    J Pediatr Endocrinol Metab; 2011; 24(1-2):69-70. PubMed ID: 21528818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
    Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
    Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
    Baştuğ F; Nalçacıoğlu H; Baş VN; Tekatlı-Çelik B; Çetinkaya H; Yel S
    Turk J Pediatr; 2018; 60(2):210-215. PubMed ID: 30325132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
    Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
    Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate for long-term control of hypercalcemia associated with Williams syndrome.
    Ismail J
    Indian Pediatr; 2015 Feb; 52(2):163-4. PubMed ID: 25691196
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
    Alos N; Eugène D; Fillion M; Powell J; Kokta V; Chabot G
    Horm Res; 2006; 65(6):289-94. PubMed ID: 16612105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.
    Lameris AL; Geesing CL; Hoenderop JG; Schreuder MF
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):757-61. PubMed ID: 24572979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypercalcemia without hypercalciuria in a previously healthy infant.
    Clark BC; Fleming R; Spaeder MC; Tuchman S
    J Pediatr Endocrinol Metab; 2012; 25(1-2):187-90. PubMed ID: 22570974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia.
    Skalova S; Cerna L; Bayer M; Kutilek S; Konrad M; Schlingmann KP
    Iran J Kidney Dis; 2013 Mar; 7(2):160-4. PubMed ID: 23485543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
    Bryowsky JJ; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute lymphoblastic leukemia accompanied by severe hypercalcemia; successful treatment with bisphosphonate].
    Ogihara T; Kikuchi Y; Imai Y; Ohsaka A; Isaka M; Oka Y
    Rinsho Ketsueki; 1995 Jan; 36(1):29-34. PubMed ID: 7715075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
    Lee DC; Lee GY
    J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.